Drug Utilization Review (DUR) Board

Drug Utilization Review (DUR) is designed to improve the quality of pharmaceutical care by ensuring that prescriptions are appropriate, medically necessary and unlikely to result in adverse medical outcomes. Medicaid’s DUR program includes prospective, online and retrospective review as well as use of standards developed by the National Council for Prescription Drug Programs (NCPDP). A board comprised of physicians and pharmacists provides guidance to Agency staff.

About the Board  

Board Meetings 

  • October 26, 2022 Agenda

     

    As the Alabama State of Emergency has been lifted, the October 26, 2022 Drug Utilization Review (DUR) Board Meeting will be held in person at the Alabama Medicaid building in Montgomery, Alabama. Voting Board members must be present to count toward a quorum. A virtual WebEx option will be available on the Medicaid website for the public to attend/observe the meeting, please find the link below.  All meetings of this Committee are open to the public.

    Alabama Medicaid DUR Meeting

    1:00 p.m. (Central Time)

     

    Join from the meeting link:

    https://medicaid.webex.com/medicaid/j.php?MTID=m8cfdba797ecd1184a5b2df07ff746706

     

     

    Join by meeting number

    Meeting number (access code): 2598 318 2435

     

    Meeting password: dVpaGqg29t4 

     

    Tap to join from a mobile device (attendees only) 


    +1-650-479-3208,,25983182435## United States Toll 

    Join by phone 
    +1-650-479-3208 United States Toll 


DUR Board Minutes 2017-2022